Improvements of predictive power of B-type natriuretic peptide on admission by mathematically estimating its discharge levels in hospitalised patients with acute heart failure

被引:2
|
作者
Anegawa, Eiji [1 ]
Takahama, Hiroyuki [1 ]
Nishimura, Kunihiro [2 ]
Onozuka, Daisuke [2 ]
Irie, Yuki [1 ]
Moriuchi, Kenji [1 ]
Amano, Masashi [1 ]
Okada, Atsushi [1 ]
Amaki, Makoto [1 ]
Kanzaki, Hideaki [1 ]
Noguchi, Teruo [1 ]
Kusano, Kengo [1 ]
Yasuda, Satoshi [1 ]
Izumi, Chisato [1 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol, Suita, Osaka, Japan
来源
OPEN HEART | 2021年 / 8卷 / 01期
关键词
heart failure; biomarkers; diastolic; systolic Pl; BNP; IMPACT; QUANTIFICATION; DYSFUNCTION; PROBNP;
D O I
10.1136/openhrt-2021-001603
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Backgrounds Earlier studies showed that in patients with heart failure (HF), circulating levels of B-type natriuretic peptide (BNP) at hospital discharge (BNPdis) are more predictive of prognosis than BNP levels on admission (BNPad). However, the mechanism underlying that difference has not been fully elucidated. We examined the association between confounding factors during hospitalisation and BNPdis in patients with HF. Methods We identified patients admitted to our hospital for HF (BNPad >= 100 pg/mL). Estimated left ventricular end-diastolic pressure (eLVEDP) was calculated using echocardiographic data. To identify the factors associated with the relation between BNPad and BNPdis, we performed a stepwise regression analysis of retrospective data. To validate that analysis, we performed a prospective study. Results Through stepwise regression of the patient data (n=688, New York Heart Association 3-4, 88%), we found age, blood urea nitrogen and eLVEDP to be significantly (p<0.05) associated with BNPdis. Through multivariate analysis after accounting for these factors, we created a formula for predicting BNP levels at discharge (predicted-BNPdis) from BNPad and other parameters measured at admission (p<0.05). By statistically adjusting for these factors, the prognostic power of BNPad was significantly improved (p<0.001). The prospective study also confirmed the strong correlation between predicted-BNPdis and BNPdis (n=104, r=0.625, p<0.05). Conclusion This study showed that statistically accounting for confounding factors affecting BNP levels improves the predictive power of BNP levels measured at the time of hospital admission, suggesting that these confounding factors are associated with lowering predictive power of BNP on admission.
引用
收藏
页数:6
相关论文
共 50 条
  • [11] B-type natriuretic peptide as a marker for heart failure in patients with acute stroke
    Koenig, Matthew A.
    Puttgen, H. Adrian
    Prabhakaran, Vivek
    Reich, Daniel
    Stevens, Robert D.
    INTENSIVE CARE MEDICINE, 2007, 33 (09) : 1587 - 1593
  • [12] B-type natriuretic peptide is associated with post-discharge stroke in hospitalized patients with heart failure
    Hotsuki, Yu
    Sato, Yu
    Yoshihisa, Akiomi
    Watanabe, Koichiro
    Kimishima, Yusuke
    Kiko, Takatoyo
    Yokokawa, Tetsuro
    Abe, Satoshi
    Misaka, Tomofumi
    Sato, Takamasa
    Oikawa, Masayoshi
    Kobayashi, Atsushi
    Yamaki, Takayoshi
    Kunii, Hiroyuki
    Nakazato, Kazuhiko
    Takeishi, Yasuchika
    ESC HEART FAILURE, 2020, 7 (05): : 2508 - 2515
  • [13] Different trajectories and significance of B-type natriuretic peptide, congestion and acute kidney injury in patients with heart failure
    Beltrami, Matteo
    Ruocco, Gaetano
    Ibrahim, Aladino
    Lucani, Barbara
    Franci, Beatrice
    Nuti, Ranuccio
    Palazzuoli, Alberto
    INTERNAL AND EMERGENCY MEDICINE, 2017, 12 (05) : 593 - 603
  • [14] B-type natriuretic peptide levels and benign adiposity in obese heart failure patients
    Katsi, Vasiliki
    Marketou, Maria
    Antonopoulos, Alexios S.
    Vrachatis, Dimitrios
    Parthenakis, Fragkiskos
    Tousoulis, Dimitris
    HEART FAILURE REVIEWS, 2019, 24 (02) : 219 - 226
  • [15] Prognosis of Stage A or B Heart Failure Patients With Elevated B-type Natriuretic Peptide Levels
    Daniels, Lori B.
    Clopton, Paul
    Jiang, Kevin
    Greenberg, Barry
    Maisel, Alan S.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (02) : 93 - 98
  • [16] B-type natriuretic peptide levels and benign adiposity in obese heart failure patients
    Vasiliki Katsi
    Maria Marketou
    Alexios S. Antonopoulos
    Dimitrios Vrachatis
    Fragkiskos Parthenakis
    Dimitris Tousoulis
    Heart Failure Reviews, 2019, 24 : 219 - 226
  • [17] N-Terminal B-type Natriuretic Peptide in Heart Failure
    Richards, Arthur Mark
    HEART FAILURE CLINICS, 2018, 14 (01) : 27 - +
  • [18] Incremental Prognostic Value of Discordant Amino Terminal Pro B-type Natriuretic Peptide Compared to B-type Natriuretic Peptide Levels in Stable Patients with Heart Failure
    Grodin, Justin L.
    Hammadah, Muhammad
    Hazen, Stanley L.
    Tang, W. H. W.
    CIRCULATION, 2014, 130
  • [19] The role of b-type natriuretic peptide in heart failure management
    Newton, Phillip J.
    Betihavas, Vasiliki
    Macdonald, Peter
    AUSTRALIAN CRITICAL CARE, 2009, 22 (03) : 117 - 123
  • [20] B-type natriuretic peptide and acute heart failure: Fluid homeostasis, biomarker and therapeutics
    Torres-Courchoud, I.
    Chen, H. H.
    REVISTA CLINICA ESPANOLA, 2016, 216 (07): : 393 - 398